Back to PathoKing

Psoriasis module

Psoriasis

Connect IL-23/Th17 immune activation to accelerated keratinocyte turnover, plaques, nail and joint disease, triggers, severity assessment, and targeted treatment.

intermediate30 min

Clinically reviewed by Mark · NMC-registered nurse

Aetiology

What starts Psoriasis?

Different triggers converge on the condition's central pathological process.

Polygenic susceptibility

Typical setting: Variants involving antigen presentation, NF-kappa-B, and IL-23/Th17 pathways lower the activation threshold.

Risk genes interact with exposures rather than determining a fixed course.

Streptococcal infection

Typical setting: Pharyngeal infection can precede guttate psoriasis, especially in younger people.

Immune cross-reactivity and T-cell activation trigger widespread small plaques.

Skin trauma

Typical setting: Cuts, friction, tattoos, or sunburn can produce plaques along injured skin.

The Koebner phenomenon reflects local inflammatory activation in predisposed tissue.

Medicines

Typical setting: Lithium, beta blockers, antimalarials, interferons, and withdrawal of systemic corticosteroids can provoke or worsen disease.

Drug effects alter immune signalling or rebound inflammation.

Lifestyle and systemic stressors

Typical setting: Smoking, alcohol excess, obesity, and psychological stress associate with activity and comorbidity.

Adipose inflammation and behavioural factors can reinforce systemic inflammatory burden.

Mechanism chain

Cause and effect

Follow each link and use it to predict the next clinical consequence.

1

A trigger activates innate skin immunity

Dendritic cells respond to danger signals in genetically susceptible skin.

2

IL-23/Th17 and TNF pathways expand

Effector cytokines recruit and activate further immune cells.

Checking account access...